Colorectal Cancer News & Features
Women with poor metabolic health have a greater risk of colorectal cancer than those with increased weight.
Chemotherapy may be overused among young and middle-aged adults with colon cancer, with the addition of adjuvant chemotherapy not resulting in a matched survival benefit.
Geographic location was seen to affect disease stage at diagnosis among people with colorectal cancer who live in ethnically or racially segregated communities.
An assessment of the use of mammography and colonoscopy among fee-for-service Medicare beneficiaries before and after the Affordable Care Act demonstrates the impact of out-of-pocket costs in this population.
Moderate but not vigorous activity proved beneficial for patients with metastatic colorectal cancer.
Clinical Trial: Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety (IOCCRC)
Clinical trial focusing on 5-FU for colorectal patients. Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety (IOCCRC)
Clinical trial focusing on biomarker analysis and metastatic colorectal cancer. Biomarker Analysis for Patients With Metastatic Colorectal Cancer (MCC)
Clinical Trial: Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer (ACROBATICC)
Clinical trial focusing on biomarker analysis for translational integration in colorectal cancer. Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer (ACROBATICC)
Clinical trial focusing on colorectal cancer prevention. Ohio Colorectal Cancer Prevention Initiative (OCCPI)
Clinical trial focusing on familial colorectal cancer registry. Familial Colorectal Cancer Registry in Hispanics (PURIFICAR)
This fact sheet reviews common sites of cancer metastasis, methods of spread, treatment, and additional details.
Patients with metastatic colorectal cancer can use this fact sheet to learn more about personalized medicine and KRAS gene testing.
This fact sheet answers some commonly asked questions about colorectal cancer screening.
Treatment for colorectal cancer can be stressful and cause lasting changes to the body. This fact sheet offers tips for coping with the disease.
This patient fact sheet explains two tests used in an approach called "personalized medicine." Doctors use these tests to plan colorectal cancer treatment that will be the most effective for an individual patient.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Pediatric Hepatocellular Carcinoma: Challenges and Solutions
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|